Senior Medical Science Liaison
About the role
Lundbeck is a global biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Lundbeck employees are inspired and driven by our purpose to advance brain health and transform lives.
This is a field-based position with opportunities available across multiple U.S. regions, including the Northeast, Mid-Atlantic, Southeast, Texas, Central Gulf, Pacific Northwest, Upper Midwest, and Great Lakes. Candidates may be considered for opportunities across these regions based on their geographic location, qualifications, and evolving business needs. The specific geographic territory will be determined during the hiring process based on the selected candidate's location and business requirements. Candidates must reside within an assigned territory and have reasonable access to a major airport to support required travel.
The Senior Medical Science Liaison (Sr MSL), Rare Epilepsies provides advanced, field-based medical and scientific leadership in support of Lundbeck's NeuroRare focus on developmental and epileptic encephalopathies. This role serves as a strategic pre-launch scientific partner to external experts and internal stakeholders, generating high-quality, actionable insights that inform evidence strategy, disease education, portfolio decision-making, and launch readiness. The Sr MSL is expected to demonstrate outcome-oriented leadership, scientific depth, and insight generation that directly advances NeuroRare medical strategy, strengthens external scientific credibility, and shapes the disease environment.
Responsibilities
- Strategic Scientific Engagement & Insight Generation: Establishes and sustains deep, longitudinal scientific partnerships with Key Opinion Leaders (KOLs), Centers of Excellence, and investigators working in rare epilepsies. Serves as a trusted scientific expert through high-quality, compliant scientific exchange that advances understanding of disease biology, unmet need, endpoints, and emerging evidence. Acts as a primary generator of pre-launch actionable field medical insights by systematically testing scientific value narratives, differentiation hypotheses, and evidence gaps through external engagement. Synthesizes and communicates high-quality insights with clear implications for evidence strategy, publication planning, disease education, and portfolio